Market Overview:
The global minimally invasive hemodynamic monitoring devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in hemodynamic monitoring devices, and rising demand for minimally invasive procedures. Based on type, the global minimally invasive hemodynamic monitoring devices market is segmented into desktop and portable devices. Desktop devices are further sub-segmented into standalone and integrated systems. Portable devices are further sub-segmented into handheld and bedside monitors. The desktop segment is expected to dominate the global minimally invasive hemodynamic monitoringdevices market during the forecast period owing to its large installed base and growing demand for advanced features in hemodynamic monitors.
Product Definition:
A minimally invasive hemodynamic monitoring device is a medical device that is inserted into a patient's body in order to measure their heart function and blood pressure. These devices are important because they can provide doctors with information about a patient's heart health that can help them make decisions about treatment options.
Desktop:
The global demand for the minimally invasive hemostatic market size was valued at USD 1.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Portable:
The portable and it’s usage in minimally invasive hemodynamic monitoring devices market is expected to grow at a lucrative rate during the forecast period. The factors that propel the growth of this market include increasing prevalence of cardiovascular diseases, growing geriatric population base, rising healthcare awareness among people and technological advancements pertaining to development of novel products.
Application Insights:
The other application segment accounted for the largest share in 2017 and is expected to grow at a significant rate over the forecast period. The global market penetration of these devices is increasing with the growing incidence of cardiovascular diseases, which are one of the leading causes of death globally. According to WHO, every year around 17 million people die from CVDs and this number is projected to reach 23 million by 2030 if proper measures are not taken. Thus, early diagnosis through MIBM devices helps in taking preventive measures against such diseases thereby driving its adoption across various applications.
The Department Of Cardiopulmonary Application (DCA) segment dominated overall revenue share in 2017 owing to factors such as high prevalence of respiratory disorders coupled with rising awareness about effective treatment options through DCA among patients suffering from respiratory illnesses worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing prevalence of cardiac disorders, growing geriatric population, and rising preference for minimally invasive surgeries over open surgeries. In addition, quick adoption of new technologies by healthcare providers is expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing government initiatives for developing advanced medical devices and a large patient pool suffering from valvular diseases such as aortic stenosis or regurgitation who require replacement surgery. Moreover, improving healthcare infrastructure in emerging countries such as India and China are expected to boost product demand over the next eight years (2030).
Latin America also presents significant opportunities due its large geriatric population base prone to various heart diseases that need surgical intervention at an early stage; thus resulting in high product demand per region (Table 1).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in hemodynamic monitoring devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Minimally Invasive Hemodynamic Monitoring Devices Market Research Report
By Type
Desktop, Portable
By Application
Department of Cardiopulmonary, Department of Neurosurgery, ICU/CCU, Department of Emergency, Other
By Companies
Edwards Lifesciences, Philips, ICU Medical, Panasonic, Cheetah Medical, GE, Nihon Kohden, Draeger, Schwarzer Cardiotek, Getinge (Pulsion), Cnsystems, Mindray, LIDCO, Uscom, Deltex Medical, Osypka Medical, Baolihao
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Minimally Invasive Hemodynamic Monitoring Devices Market Report Segments:
The global Minimally Invasive Hemodynamic Monitoring Devices market is segmented on the basis of:
Types
Desktop, Portable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Department of Cardiopulmonary, Department of Neurosurgery, ICU/CCU, Department of Emergency, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Edwards Lifesciences
- Philips
- ICU Medical
- Panasonic
- Cheetah Medical
- GE
- Nihon Kohden
- Draeger
- Schwarzer Cardiotek
- Getinge (Pulsion)
- Cnsystems
- Mindray
- LIDCO
- Uscom
- Deltex Medical
- Osypka Medical
- Baolihao
Highlights of The Minimally Invasive Hemodynamic Monitoring Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Desktop
- Portable
- By Application:
- Department of Cardiopulmonary
- Department of Neurosurgery
- ICU/CCU
- Department of Emergency
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Minimally Invasive Hemodynamic Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Minimally invasive hemodynamic monitoring devices are medical devices that use a small catheter to measure blood pressure, heart rate, and other vital signs without the need for an incision.
Some of the major companies in the minimally invasive hemodynamic monitoring devices market are Edwards Lifesciences, Philips, ICU Medical, Panasonic, Cheetah Medical, GE, Nihon Kohden, Draeger, Schwarzer Cardiotek, Getinge (Pulsion), Cnsystems, Mindray, LIDCO, Uscom, Deltex Medical, Osypka Medical, Baolihao.
The minimally invasive hemodynamic monitoring devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Minimally Invasive Hemodynamic Monitoring Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Minimally Invasive Hemodynamic Monitoring Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Minimally Invasive Hemodynamic Monitoring Devices Market - Supply Chain
4.5. Global Minimally Invasive Hemodynamic Monitoring Devices Market Forecast
4.5.1. Minimally Invasive Hemodynamic Monitoring Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Minimally Invasive Hemodynamic Monitoring Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Minimally Invasive Hemodynamic Monitoring Devices Market Absolute $ Opportunity
5. Global Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Type
5.3.1. Desktop
5.3.2. Portable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Application
6.3.1. Department of Cardiopulmonary
6.3.2. Department of Neurosurgery
6.3.3. ICU/CCU
6.3.4. Department of Emergency
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Minimally Invasive Hemodynamic Monitoring Devices Demand Share Forecast, 2019-2026
9. North America Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Application
9.4.1. Department of Cardiopulmonary
9.4.2. Department of Neurosurgery
9.4.3. ICU/CCU
9.4.4. Department of Emergency
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Type
9.7.1. Desktop
9.7.2. Portable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Minimally Invasive Hemodynamic Monitoring Devices Demand Share Forecast, 2019-2026
10. Latin America Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Application
10.4.1. Department of Cardiopulmonary
10.4.2. Department of Neurosurgery
10.4.3. ICU/CCU
10.4.4. Department of Emergency
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Type
10.7.1. Desktop
10.7.2. Portable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Minimally Invasive Hemodynamic Monitoring Devices Demand Share Forecast, 2019-2026
11. Europe Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Application
11.4.1. Department of Cardiopulmonary
11.4.2. Department of Neurosurgery
11.4.3. ICU/CCU
11.4.4. Department of Emergency
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Applicaton
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Type
11.7.1. Desktop
11.7.2. Portable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Minimally Invasive Hemodynamic Monitoring Devices Demand Share, 2019-2026
12. Asia Pacific Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Application
12.4.1. Department of Cardiopulmonary
12.4.2. Department of Neurosurgery
12.4.3. ICU/CCU
12.4.4. Department of Emergency
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Type
12.7.1. Desktop
12.7.2. Portable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Minimally Invasive Hemodynamic Monitoring Devices Demand Share, 2019-2026
13. Middle East & Africa Minimally Invasive Hemodynamic Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Application
13.4.1. Department of Cardiopulmonary
13.4.2. Department of Neurosurgery
13.4.3. ICU/CCU
13.4.4. Department of Emergency
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Minimally Invasive Hemodynamic Monitoring Devices Market Size and Volume Forecast by Type
13.7.1. Desktop
13.7.2. Portable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Minimally Invasive Hemodynamic Monitoring Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Minimally Invasive Hemodynamic Monitoring Devices Market: Market Share Analysis
14.2. Minimally Invasive Hemodynamic Monitoring Devices Distributors and Customers
14.3. Minimally Invasive Hemodynamic Monitoring Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Edwards Lifesciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Philips
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ICU Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Panasonic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cheetah Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GE
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nihon Kohden
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Draeger
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Schwarzer Cardiotek
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Getinge (Pulsion)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cnsystems
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Mindray
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. LIDCO
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Uscom
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Deltex Medical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Osypka Medical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Baolihao
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
